On 20 April 2016 the Cabinet of Ministers of Ukraine adopted
Resolution No. 312 amending the Procedure for State Registration
(Registration Renewal) of Medicinal Products (the Procedure.) The
changes took effect on May 13.
In particular, Resolution No. 312 provides for the following
The regulation for the expert examination of registration
materials shall now be established by the Ministry of Health of
Ukraine (MoH) upon consultation with Ministry of Economic
Development and Trade of Ukraine (MEDT).
The maximum period for the expert examination of registration
materials for medicinal products already marketed in the US, the
EU, Switzerland, Japan, Australia or Canada has been limited to 20
business days. If the State Expert Center (the Center) does not
provide its conclusions and recommendations within the indicated
period, the expert examination shall be considered as carried
The period for the adoption by MoH of its decision authorizing
or refusing the registration of medicinal products has been
shortened from one month to 10 business days. Notably, this change
affects all medicinal products rather than only those marketed in
the jurisdictions above.
The adoption of these changes will help improve access of the
outlined medicinal products to the Ukrainian market. However, in
order to ensure proper implementation of the above changes, there
are still a few steps that need to be taken.
First, as it follows from the amended Procedure, MoH should
agree with MEDT the regulation for the expert examination of
registration materials. Such regulation should replace the existing
regulation approved by MoH's Order No. 426 and should reflect
the introduced simplifications.
Second, until the substitute regulation for the expert
examination of registration materials is adopted, it is not clear
whether the Center will in fact accept the new applications and, as
such, whether the expert examination shall nevertheless be
considered as carried out, thus resulting in MoH's
authorization of the registration of medicinal products. Therefore,
it is essential that the substitute regulation for the expert
examination of registration materials be adopted in order to enable
the Procedure to operate smoothly.
Third, the Procedure does not clearly stipulate that MOH should
issue its positive decision on the registration of medicinal
products in the absence of the Center's conclusions and
recommendations (e.g., the Center fails to provide same within the
established period). In our view, it would be reasonable to amend
the Procedure such that MoH does not have the discretion to make a
decision if the Center fails to provide its conclusions and
recommendations when due, regardless of the reason of such
Dentons is the world's first polycentric global law firm. A
top 20 firm on the Acritas 2015 Global Elite Brand Index, the Firm
is committed to challenging the status quo in delivering consistent
and uncompromising quality and value in new and inventive ways.
Driven to provide clients a competitive edge, and connected to the
communities where its clients want to do business, Dentons knows
that understanding local cultures is crucial to successfully
completing a deal, resolving a dispute or solving a business
challenge. Now the world's largest law firm, Dentons'
global team builds agile, tailored solutions to meet the local,
national and global needs of private and public clients of any size
in more than 125 locations serving 50-plus countries.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
You are cordially invited to our workshop on processing of employees’ personal data in light of the new EU Regulation on Personal Data Protection (GDPR). The meeting is organized by Dentons together with the American Chamber of Commerce in Poland.
Dentons will hold a Competition Breakfast Seminar on February 28, 2017 titled: Rebates and discounts under EU competition law – lessons of the Intel case. Renowned competition lawyer James Venit from Dentons’ Brussels office will be joining co-heads Tihamér Tóth and Tünde Gönczöl of Dentons Budapest’s
You are cordially invited to a practical seminar on private antitrust enforcement in light of the soon to be implemented Damages Directive, which we address to the banking and finance sector. During the seminar we will present new tools designed for cartel damages litigation in light of fast forwarding the legislative process in Poland from a lawyer’s and an economist’s perspective. We will discuss examples of private antitrust litigation from a jurisdiction where the system is already effective and consider whether third party litigation funding is an option in Poland. All these points will help you identify potential claims against other market players and prepare a defense strategy against private enforcement claims targeting your institution.
After studying bioengineering and completing a PhD in the San Francisco Bay Area and a two-year postdoctoral research fellowship in London, Mark has spent the past four years analysing global health policy.
World AIDS Day, held on the 1st December each year, provides an opportunity for people to unite in the fight against HIV and show their support for people living with, or having died as a result of, HIV.
Since the enactment of Directive 2001/83/EC ("Community Code Directive") the European Community has conducted a comprehensive review of its legislation on medicinal products. It is not only that the Community since then has adopted Directive 2004/27/EC amending the Community Code. In fact, several other acts of legislation have been issued.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).